The National Screening Laboratory for the Regional Centers of Excellence in Biodefense and Emerging Infectious Disease (NSRB) supports research directed towards the identification of small molecules that enhance our understanding of the basic biology of pathogens relevant to biodefense or emerging infectious disease, and development of new therapeutic agents against these NIAID Priority Pathogens. The NSRB provides access to small molecule collections and assistance in conducting and interpreting high-throughput screens for all investigators conducting research relevant to these aims. The NSRB also has medicinal chemistry capability to advance promising screening hits toward pharmaceutical development. Read more...